chr1-1420125-C-G
Variant summary
Our verdict is Uncertain significance. Variant got 1 ACMG points: 2P and 1B. PM2BP4
The NM_001145210.3(ANKRD65):āc.677G>Cā(p.Gly226Ala) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000319 in 1,255,614 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. G226R) has been classified as Uncertain significance.
Frequency
Consequence
NM_001145210.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 1 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
ANKRD65 | NM_001145210.3 | c.677G>C | p.Gly226Ala | missense_variant | 3/4 | ENST00000537107.6 | |
ANKRD65-AS1 | XR_946814.2 | upstream_gene_variant |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
ANKRD65 | ENST00000537107.6 | c.677G>C | p.Gly226Ala | missense_variant | 3/4 | 5 | NM_001145210.3 | P1 |
Frequencies
GnomAD3 genomes AF: 0.0000133 AC: 2AN: 150824Hom.: 0 Cov.: 33
GnomAD4 exome AF: 0.00000181 AC: 2AN: 1104686Hom.: 0 Cov.: 29 AF XY: 0.00 AC XY: 0AN XY: 533790
GnomAD4 genome AF: 0.0000133 AC: 2AN: 150928Hom.: 0 Cov.: 33 AF XY: 0.0000136 AC XY: 1AN XY: 73738
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Feb 16, 2023 | The c.677G>C (p.G226A) alteration is located in exon 3 (coding exon 2) of the ANKRD65 gene. This alteration results from a G to C substitution at nucleotide position 677, causing the glycine (G) at amino acid position 226 to be replaced by an alanine (A). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at